Indogulf Cropsciences: consolidated PAT up 24% YoY on margin gains, revenue flat at 3%
PAT +24.17% YoY · revenue +2.99% · margins expanding
₹255.78 Cr
+2.99% YoY
₹25.68 Cr
+24.17% YoY
9.98%
+1.7pp YoY
₹4.26
Indogulf Cropsciences' consolidated Q2 FY27 (quarter ended September 30, 2026) revenue grew a modest 3.0% YoY to ₹255.78 Cr (₹248.34 Cr a year ago), while consolidated PAT rose a sharper 24.2% YoY to ₹25.68 Cr (₹20.69 Cr), with basic EPS of ₹4.26 versus ₹1.73. Standalone (parent-only) revenue was ₹237.62 Cr, down 3.5% YoY, with PAT of ₹20.88 Cr, up a more modest 7.3% YoY — a visible gap versus the consolidated numbers, pointing to the Abhiprakash Globus and Indogulf Cropsciences Australia subsidiaries carrying incremental group growth that the domestic standalone book did not generate on its own. There is no tracked analyst coverage for this stock (zero analysts per available coverage trackers, and no Q2 FY27 preview turned up in search), so the print cannot be benchmarked against a street number — vsStreet is unknown.
Q2 FY-2027 vs prior quarters
The YoY profit outperformance over revenue is a margin story, not a volume story: consolidated net margin expanded to roughly 10.0% from about 8.3% a year ago, and operating (EBITDA) margin rose to near 16.5% from about 13.7%. Exceptional items were negligible in both periods (₹0.03 Cr this quarter versus ₹0.36 Cr a year ago) and do not distort the comparison. Sequentially, revenue jumped 51.7% and PAT jumped roughly 10x over the June quarter (₹2.41 Cr), but that swing is a seasonality artifact, not a trend signal — Q1 is the agri off-season and Q2 captures the kharif-linked pickup, exactly as management flagged on the last call.
The stock went into the print at ₹62.68, up 10.6% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records.
No FY27 numeric revenue/margin guidance issued. Management stated quarterly seasonality and reliance on agriculture cycle; declined to commit to growth targets. Capacity roadmap: peak ₹1100-1200 Cr current infrastructure, ₹1800 Cr post-expansion in 4-5 years.
Management issued no numeric FY27 revenue or margin guidance on the prior call, instead citing quarterly seasonality and reliance on the agriculture cycle while declining to commit to growth targets; this quarter's sharp QoQ swing is a direct illustration of that caution being well-placed, and the modest 3% YoY revenue growth (against a bearish, defensive prior-quarter tone) suggests the underlying business is still growing slowly rather than accelerating. On capacity, management had pointed to a near-term operating ceiling of ₹1,100-1,200 Cr versus a post-expansion target of ₹1,800 Cr in 4-5 years; H1 FY27 consolidated revenue of ₹424.32 Cr annualizes to roughly ₹849 Cr, still comfortably under the stated near-term ceiling. No operational one-offs, capex announcements, or capital-market transactions accompanied this result beyond routine governance items (34th AGM held September 24, 2026 with a director reappointment and secretarial auditor appointment; trading window closed ahead of results). No press release text was available to cross-check management's own framing of the quarter.
W1
Whether the margin expansion holds into H2 FY27 — consolidated OPM was ~16.5% this quarter vs ~13.7% a year ago; the next quarter will show if that gap persists outside the seasonal peak.
W2
Standalone revenue trend: it fell 3.5% YoY this quarter even as consolidated grew — watch whether the parent business stabilizes or the subsidiaries keep carrying group growth.
W3
Capacity build toward management's stated ₹1,100-1,200 Cr near-term operating ceiling — H1 FY27 consolidated revenue annualizes to ~₹849 Cr, still below that level.
Filing in INR Millions, converted to ₹ Crore (÷10). Exceptional items are immaterial both periods (consol. ₹0.032 Cr this qtr vs ₹0.358 Cr year-ago; standalone identical figures) — no adjusted-PAT split needed. EPS is quarterly, not annualized, per filing note. Filing's paid-up equity capital row shows ₹48.787 Cr at June 30, 2026 vs ₹63.224 Cr at both March 2026 and Sep 2026 — looks like a reporting anomaly in the prior quarter's row, not a real capital action; flagged, not corrected.
Informational and educational content only. Not investment advice.